The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression

Participants will receive educational materials, but will not receive MTM.

Participants will receive MTM in addition to the educational materials.

At the beginning and end of the study, participants will be asked to use a scopolamine patch. This patch is not being used to prevent motion sickness (as approved by the FDA), but instead is being used to challenge the participant's memory and thinking abilities and determine cognitive reserve.